Michael Lidsky, MD, FACS (@michael_lidsky) 's Twitter Profile
Michael Lidsky, MD, FACS

@michael_lidsky

Surgical Oncologist and Hepatopancreatobiliary Surgeon @DukeSurgery, Basic and Translational Surgeon-Scientist @DukeUniversity @DukeSurgOnc

ID: 1263888784858333184

calendar_today22-05-2020 17:45:54

420 Tweet

1,1K Followers

628 Following

Allison Martin, MD MPH (@globalsurgallie) 's Twitter Profile Photo

The best part of Twitter (X) has always been 🔥 connections with friends/colleagues from afar 🌎. So happy to get QT w/ my “old school” social media buddy Marissa Boeck MD MPH FACS—reigniting over shared health equity research interests this week Health Disparities Health Disparities Research Institute! 💟

The best part of Twitter (X) has always been 🔥 connections with friends/colleagues from afar 🌎. So happy to get QT w/ my “old school” social media buddy <a href="/KickAsana/">Marissa Boeck MD MPH FACS</a>—reigniting over shared health equity research interests this week <a href="/NIMHD/">Health Disparities</a> Health Disparities Research Institute! 💟
Duke Surgical Oncology (@dukesurgonc) 's Twitter Profile Photo

Our surgical oncologists continue to lead as PI’s of multiple clinical trials that expand options for therapy for our most vulnerable patients, including those with unresectable cancers. Michael Lidsky, MD, FACS ECOG-ACRIN Cancer Research Group

Allison Martin, MD MPH (@globalsurgallie) 's Twitter Profile Photo

Pleased to contribute SURGERY Journal editorial w/ 2⭐️'s, Michela Fabricius (she/her) & Amika Ekanem. Thoughtful planning re: operative approach is 🔑 to limit morbidity & mortality for pts with resectable gallbladder cancer. 🚨: Gen surg PD's-lookout for Amika Ekanem this application cycle!

Dr. jordan berlin (@jordanberlin5) 's Twitter Profile Photo

one of the most important studies out there right now. Kudos to Michael Lidsky, MD, FACS and surgical colleagues for getting this study approved--the definitive answer to a decades old question.

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

With the increase in registry use for cancer research, knowing when to use which dataset is paramount to address each research question appropriately. Allison Martin, MD MPH Zhi Ven Fong, MD MPH DrPH et al provide guidance on this topic in their new review: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

With the increase in registry use for cancer research, knowing when to use which dataset is paramount to address each research question appropriately. 

<a href="/globalsurgallie/">Allison Martin, MD MPH</a> <a href="/ZhiVenFongMD/">Zhi Ven Fong, MD MPH DrPH</a> et al provide guidance on this topic in their new review: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
Duke General Surgery Residency (@dukesurgres) 's Twitter Profile Photo

We just had a great talk by Coach Scheyer of Duke Basketball on how to recruit talent! Perfect pump up for the first of our town halls tonight! Sign up here: duke.is/GSUTownHalls20…🏀💙🏀 Duke Basketball Jon Scheyer

We just had a great talk by Coach Scheyer of Duke Basketball on how to recruit talent! Perfect pump up for the first of our town halls tonight! Sign up here: duke.is/GSUTownHalls20…🏀💙🏀 <a href="/dukebasketball/">Duke Basketball</a> <a href="/JonScheyer/">Jon Scheyer</a>
Michael Lidsky, MD, FACS (@michael_lidsky) 's Twitter Profile Photo

So fun to have one of my mentors, colleagues + friends, Peter Kingham visit Durham and give an inspiring Grand Rounds Duke Surgery -incredible to see what he, Prof Alatise, and the entire ARGO Research team have accomplished to advance cancer care in Nigeria. Memorial Sloan Kettering Cancer Center

ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek

#ClinicalTrial EA2222/PUMP, led by <a href="/michael_lidsky/">Michael Lidsky, MD, FACS</a>, is a randomized phase 3  study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: <a href="/MichaelDAngeli2/">Michael D’Angelica</a>, <a href="/skmaithel/">Shishir K. Maithel</a>, <a href="/AndreaCercek/">Andrea Cercek</a>